![Fig 1 New Layout Revised 1 1 Copy[6]](https://img.medestheticsmag.com/files/base/allured/all/image/2024/12/Fig_1_new_layout_revised_1_1_copy_6_.67644cc1a382d.png?auto=format%2Ccompress&q=70&w=700)
Dermalogic Surgery, the journal of the American Society for Dermatologic Surgery, has published clinical data evaluating Ourself Skincare’s tiered-release vesicles (TRVs), highlighting that TRVs have the potential to enable the delivery of large, bioactive molecules directly into the epidermis and dermis, according to a Dec. 12 press release.
The technology addresses the skin's outermost layer, a barrier that limits the effectiveness of skin care products, blocking essential ingredients from reaching deeper layers, according to the release.
TRVs provide deep ingredient delivery, according to the release, sending larger molecules and peptides directly to the outer layer of the skin to improve loss of volume, lines and wrinkles, and uneven pigmentation.
"Tiered-Release Vesicles represent a revolutionary advancement in dermal delivery technology, addressing a stagnation in the industry that has persisted for over four decades," said Ashish C. Bhatia, MD, FAAD, author and board-certified dermatologist and Mohs surgeon at Oak Dermatology.
